U.S. flag

An official website of the United States government

NM_000179.3(MSH6):c.3478G>C (p.Val1160Leu) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Mar 18, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000129922.7

Allele description [Variation Report for NM_000179.3(MSH6):c.3478G>C (p.Val1160Leu)]

NM_000179.3(MSH6):c.3478G>C (p.Val1160Leu)

Gene:
MSH6:mutS homolog 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_000179.3(MSH6):c.3478G>C (p.Val1160Leu)
HGVS:
  • NC_000002.12:g.47804949G>C
  • NG_007111.1:g.26803G>C
  • NG_008397.1:g.105727C>G
  • NM_000179.3:c.3478G>CMANE SELECT
  • NM_001281492.2:c.3088G>C
  • NM_001281493.2:c.2572G>C
  • NM_001281494.2:c.2572G>C
  • NP_000170.1:p.Val1160Leu
  • NP_000170.1:p.Val1160Leu
  • NP_001268421.1:p.Val1030Leu
  • NP_001268422.1:p.Val858Leu
  • NP_001268423.1:p.Val858Leu
  • LRG_219t1:c.3478G>C
  • LRG_219:g.26803G>C
  • LRG_219p1:p.Val1160Leu
  • NC_000002.11:g.48032088G>C
  • NM_000179.2:c.3478G>C
  • p.V1160L
Protein change:
V1030L
Links:
dbSNP: rs376799914
NCBI 1000 Genomes Browser:
rs376799914
Molecular consequence:
  • NM_000179.3:c.3478G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281492.2:c.3088G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281493.2:c.2572G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281494.2:c.2572G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000184740Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Dec 14, 2021)
germlineclinical testing

Citation Link,

SCV002528035Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Uncertain significance
(Mar 18, 2022)
germlinecuration

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes.

Mizukami K, Iwasaki Y, Kawakami E, Hirata M, Kamatani Y, Matsuda K, Endo M, Sugano K, Yoshida T, Murakami Y, Nakagawa H, Spurdle AB, Momozawa Y.

EBioMedicine. 2020 Oct;60:103033. doi: 10.1016/j.ebiom.2020.103033. Epub 2020 Sep 24.

PubMed [citation]
PMID:
32980694
PMCID:
PMC7519363

Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.

Breast Cancer Association Consortium., Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, Alonso MR, Álvarez N, Herraez B, Fernandez V, Núñez-Torres R, Osorio A, Valcich J, Li M, et al.

N Engl J Med. 2021 Feb 4;384(5):428-439. doi: 10.1056/NEJMoa1913948. Epub 2021 Jan 20.

PubMed [citation]
PMID:
33471991
PMCID:
PMC7611105

Details of each submission

From Ambry Genetics, SCV000184740.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The p.V1160L variant (also known as c.3478G>C), located in coding exon 6 of the MSH6 gene, results from a G to C substitution at nucleotide position 3478. The valine at codon 1160 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Sema4, Sema4, SCV002528035.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024